Background: Mitral valve prolapse has been associated with increased risk of ventricular arrhythmias. We aimed to examine whether certain cardiac imaging characteristics are associated with papillary muscle origin of ventricular arrhythmias in these patients.
INTRODUCTION
Mitral valve prolapse (MVP) is a relatively common valvular abnormality that affects approximately 1-3% of the population. 1 In general, outcomes are favorable and the condition is largely benign. 2, 3 However, recent studies have suggested that some patients with MVP are at increased risk for ventricular arrhythmias that may precipitate sudden cardiac death, which was reported to occur at rates up to 0.2-0.4% per year. [4] [5] [6] The "malignant MVP syndrome" tends to affect younger patients without typical cardiovascular comorbidities such as hypertension, diabetes mellitus, and coronary artery disease. 7 Additionally, certain echocardiographic characteristics may be associated with an increased risk of ventricular arrhythmias in these patients, such as bileaflet prolapse, increased anterior mitral leaflet thickness, and moderate to severe mitral regurgitation. [8] [9] [10] [11] Fibrosis of the papillary muscles and inferobasal left ventricular wall may provide substrate for ventricular ectopy in patients with MVP, and several studies have included data obtained during electrophysiologic (EP) mapping to implicate these regions as arrhythmogenic origins in these patients. 6, 8, 12 Other studies have utilized cardiac magnetic resonance imaging (CMR) to demonstrate late gadolinium enhancement (LGE) in the papillary muscle region, suggestive of fibrosis. 13 No studies to date have demonstrated the relationship of leaflet characteristics, papillary muscle fibrosis, and in vivo EP mapping data. 6, 13, 14 In the present study, we retrospectively analyzed transthoracic echocardiograms (TTEs) and CMRs with in vivo EP mapping data for patients at our center with MVP and ventricular ectopy to better define the imaging characteristics in understanding the involvement of papillary muscles in ventricular arrhythmogenesis in these patients.
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METHODS
Patient selection
We screened electronic medical records from 2007 to 2016 to identify all patients with a clinical diagnosis of MVP (documented on either TTE or CMR) in our institution and cross-referenced the resulting patients with our ventricular tachycardia (VT) ablation database to identify those who underwent EP study (EPS) over the time period. Our institutional review board approved the study with waiver of consent.
Echocardiography
An experienced echocardiographer (YH) retrospectively reviewed each TTE. MVP was characterized as billowing of any portion of the mitral leaflets ≥2 mm above the annular plane in the parasternal long axis view in systole. 15 The prolapsed distance was measured for each leaflet as the maximum excursion of the leaflet beyond the mitral annular plane as defined by a line connecting the inferolateral mitral annulus to the aortomitral junction during systole (Fig. 1A) . 13 We measured the anterior and posterior diastolic maximum mitral leaflet thickness as shown in Figures 1B-C. The echocardiographic review was blinded to EPS results.
CMR
For patients who had CMR, we reviewed the cine images to confirm the diagnosis of MVP, which again was characterized as billowing of any portion of the mitral leaflets ≥2 mm above the annular plane. 13 
EP study
In all patients, a 3D electroanatomic map (CARTO, Biosense Webster, Diamond Bar, CA, USA) was created during sinus or paced rhythm to identify areas of low voltage and abnormal electrograms consistent with scar, using a 3.5-mm open irrigation tip catheter (Navistar Thermocool, Biosense Webster) as previously described. [16] [17] [18] 
Statistical analysis
We present the data as mean ± standard deviation or median ± interquartile range. We used Wilcoxon rank-sum test and Fisher's exact test to compare groups. A P-value of <0.05 was considered significant. All statistical analyses were performed using PRISM 7.0 (GraphPad Software, Inc., La Jolla, CA)
RESULTS
The initial screen identified 189 patients meeting criteria for MVP on CMR or TTE, as well as a history of EPS or ablative procedure for ventricular tachycardia, premature ventricular contractions, or both ( Fig. 2 ). Of these, 171 were excluded, including 148 for lack of EPS performed at our center and 23 for lack of imaging available at our center to ensure the presence of MVP. Of the 18 patients who met inclusion criteria, 4 underwent both TTE and CMR, 11 TTE only, and 3 CMR only.
We classified patients as cohort 1 or cohort 2, based on the method of imaging: those who underwent TTE (n = 15) comprised cohort 1, while those who underwent CMR (n = 7) comprised cohort 2.
Electrophysiologic data and baseline clinical characteristics (patient cohort 1)
Fifteen patients (11 women, mean age 48.2 years; mean left ventricular ejection fraction 53.3%) with MVP as well as EP study and TTE performed at our center were included in cohort 1. The characteristics of the patients in cohort 1 are shown in Table 1 . Eight (53.3%) patients were pap (+), while 7 (46.7%) were pap (−). Patients in the pap (+) group were more likely to be women (100% vs. 42.9%, P = 0.026). There was no statistically significant difference in the number of patients with T-wave inversions inferiorly between the pap (+) and pap (−) groups (37.5% vs. 28.6%, P = 1.000). Indications for ablation included ventricular tachycardia, premature ventricular contractions, or both and were similar in proportions between groups. VT was sustained in 4 patients and there was no difference between groups. There were also 3 patients with PVC-induced ventricular fibrillation, 2 of which suffered out-of-hospital cardiac arrest and survived. Both of those patients were females, aged 31 and 40 years old, respectively, and were pap(+). The third patient had an implantable cardioverter defibrillator (ICD) already implanted and received shocks from the device, and was pap (−). All other baseline demographic characteristics were similar between groups (Table 1) . Twelve-lead ECGs that correspond to patients with anterolateral papillary muscle-based ectopy, posteromedial papillary muscle-based ectopy, and nonpapillary muscle-based ectopy are shown in Figure 3 .
Echocardiographic and EP study findings (patient cohort 1)
TTE exams were performed within a median of 11 days prior to the EP study. Measurements of leaflet thickness and prolapse distance, as well as degree of mitral regurgitation and EP study findings are shown in Table 2 . There were no statistically significant dif- percentages of patients with less than moderate mitral regurgitation (87.5% vs. 100.0%, P = 1.000) or moderate and greater mitral regurgitation (12.5% vs. 0.0%, P = 1.000) between the pap (+) and pap (−) groups, respectively.
CMR evidence of LGE in the papillary muscles (patient cohort 2)
Seven patients (6 women, mean age 52.0 years, mean left ventricular ejection fraction 53.6%) with MVP as well as EPS and CMR performed at our center were included in cohort 2. The distribution of age, body surface area, ejection fraction, and other baseline characteristics, including indication for ablation, was similar between the groups. CMR exams were performed within a median of 60 days [29.5-80.5] prior to the EPS. The characteristics of the patients in cohort 2 are depicted in Table 3 . Five patients (71.4%) were pap(+), while 2 (28.6%) were pap(−). The same pap(+) patients were found to be LGE+ and pap(−) were LGE − . Patients who were pap (+) were significantly more likely to be LGE+ than those who were pap (−) (5/5 vs. 0/2, P = 0.048).
Findings from CMR and the EP study results are shown in Table 4 .
In 3 of the 5 LGE+ patients, the CMR LGE corresponded with the origin of ventricular ectopy at EPS (Fig. 4A-C) . Both of the other 2 LGE+ patients had diffuse unipolar scar involving both papillary muscles in the setting of multiple PVC morphologies-some possibly 
TA B L E 2 Cohort 1 echocardiographic measurements and EP study results
DISCUSSION
In patients with MVP and PVCs/VT undergoing EPS and catheter ablation, we identified a few characteristics that were associated with a papillary muscle site of origin. First, female gender was significantly associated with papillary muscle-based ventricular ectopy as determined by the EPS. Second, MVP patients with more significant anterior involvement in bileaflet prolapse, which we found as an anterior to posterior prolapse ratio >0.45, were significantly more likely to have papillary muscle-based ventricular ectopy compared to those with a ratio <0.45. This study suggests that imaging characteristics and demographic data might be associated with papillary muscle origin of ventricular ectopy as determined by EPS.
Patients with MVP who develop ventricular arrhythmias appear to be disproportionately more likely to have a fascicular or papillary muscle origin of arrhythmia compared to patients with PVC/VTs but no MVP. 19 The mechanism for papillary muscle involvement remains unclear, and may be related to increased traction on the papillary muscles, endocardial friction lesions, and coronary microemboli from platelet-fibrin aggregates adjacent to the prolapsing mitral valve leaflets. 20, 21 An elegant study by Marra et al. incorporated CMR with Syndrome." 8 We found no significant differences in anterior or posterior mitral leaflet thickness, nor absolute mitral leaflet prolapse distance between patients with papillary muscle-based ectopy versus those without. We did find, however, that more symmetric prolapse and thus greater bileaflet involvement, as evidenced by the increased ratio of anterior to posterior leaflet prolapsed distance, may be associated with papillary muscle focus of ectopy in MVP patients.
TA B L E 4 Cohort 2 CMR measurements and EP study results
Patient
Using our CMR imaging data, we found that patients with LGE in the papillary muscle region were significantly more likely to have papillary muscle-based ventricular ectopy as determined by the EP study. This is consistent with previous studies suggesting that the presence of LGE on CMR imaging indicates the presence of fibrosis, and this has been postulated to be a source of ventricular arrhythmias in these patients. 6, 8, 12 The involvement of the papillary muscles as sites of origin of recurrent malignant ventricular arrhythmias was previously an underrecognized entity, though it has gained some recent recognition. 24 The ability to predict the presence of papillary muscle-based ventricular arrhythmias carries important implications for the treatment of patients with these arrhythmias. Catheter ablation of papillary musclebased ectopic foci can be technically challenging due to issues with catheter stability, deep intramural sites of origin, and the need to ablate at the base of the papillary muscle. 24, 25 Further, surgical mitral valve repair or replacement has been shown in some studies to reduce the burden of malignant arrhythmias in patients with papillary musclebased ectopy-even in the patients who do not otherwise meet criteria for valve surgery. 26, 27 The availability of these treatment options advocates for better recognition of papillary muscle-based ectopy in MVP patients. Thus, our findings that female gender, greater relative anterior involvement in bileaflet prolapse, and the presence of LGE on CMR may serve as valuable noninvasive methods for detecting the presence of papillary muscle-based ventricular ectopy in patients with MVP.
Major limitations of this study are its retrospective nature and small sample size. Given the strict inclusion criteria and availability of imaging studies at our institution, only 18 distinct patients were included between cohorts 1 and 2. Because maintenance of adequate catheter contact on the papillary muscles throughout the cardiac cycle can be difficult, the electrogram signal recorded from these catheters can be variable. It is also important to recognize that since the voltage criteria for LV scar were derived from the actual LV myocardium rather than the papillary muscles, the optimal voltage cutoff value to best define papillary muscle scar may actually be different.
CONCLUSIONS
The use of multiple imaging modalities in conjunction with in vivo EP mapping data can be helpful to identify papillary muscle site of PVC/VT origin in patients with MVP. Female sex, echocardiographic evidence of bileaflet involvement with greater anterior prolapse, and papillary muscle LGE on CMR imaging are associated with papillary muscle origin of ventricular ectopy in these patients. Further research is needed to better elucidate the mechanisms behind these findings and thus better risk-stratify these individuals. 
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